Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Reduced ocular allergy with fixed-combination 0.2% brimonidine-0.5% timolol.

Alvarado JA.

Arch Ophthalmol. 2007 May;125(5):717; author reply 717-8. No abstract available.

PMID:
17502523
2.

Twice-daily 0.2% brimonidine-0.5% timolol fixed-combination therapy vs monotherapy with timolol or brimonidine in patients with glaucoma or ocular hypertension: a 12-month randomized trial.

Sherwood MB, Craven ER, Chou C, DuBiner HB, Batoosingh AL, Schiffman RM, Whitcup SM.

Arch Ophthalmol. 2006 Sep;124(9):1230-8.

PMID:
16966616
3.
4.

Comparison of brimonidine/latanoprost and timolol/dorzolamide: two randomized, double-masked, parallel clinical trials.

Zabriskie N, Netland PA; Brimonidine with Latanoprost Study Groups 1 and 2..

Adv Ther. 2003 Mar-Apr;20(2):92-100.

PMID:
12836809
5.
8.

Comparison of latanoprost, brimonidine and a fixed combination of timolol and dorzolamide on circadian intraocular pressure in patients with primary open-angle glaucoma and ocular hypertension.

Orzalesi N, Rossetti I, Bottoli A, Invernizzi T, Fumagalli E, Fogagnolo P.

Acta Ophthalmol Scand Suppl. 2002;236:55. No abstract available.

PMID:
12390144
9.

Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: six-month comparison of efficacy and tolerability.

Sall KN, Greff LJ, Johnson-Pratt LR, DeLucca PT, Polis AB, Kolodny AH, Fletcher CA, Cassel DA, Boyle DR, Skobieranda F.

Ophthalmology. 2003 Mar;110(3):615-24.

PMID:
12623832
10.
11.

Brimonidine/Timolol: a viewpoint by Francisco J. Goñi.

Goñi FJ.

Drugs Aging. 2006;23(9):762-3. No abstract available.

PMID:
17020402
12.

Brimonidine and latanoprost as adjunctive therapy.

Camras CB.

Ophthalmology. 2004 Feb;111(2):410-1. No abstract available.

PMID:
15019405
14.

Efficacy and safety of the latanoprost/timolol maleate fixed combination vs concomitant brimonidine and latanoprost therapy.

Stewart WC, Stewart JA, Day DG, Sharpe ED, Jenkins JN.

Eye (Lond). 2004 Oct;18(10):990-5.

PMID:
15037890
15.
16.

Twenty-four-hour efficacy of the brimonidine/timolol fixed combination versus therapy with the unfixed components.

Konstas AG, Katsimpris IE, Kaltsos K, Georgiadou I, Kordelou A, Nelson LA, Stewart WC.

Eye (Lond). 2008 Nov;22(11):1391-7.

PMID:
17571086
17.
18.

Fixed-combination brimonidine-timolol versus latanoprost in glaucoma and ocular hypertension: a 12-week, randomized, comparison study.

Katz LJ, Rauchman SH, Cottingham AJ Jr, Simmons ST, Williams JM, Schiffman RM, Hollander DA.

Curr Med Res Opin. 2012 May;28(5):781-8. doi: 10.1185/03007995.2012.681036.

PMID:
22458918
19.
20.

Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapy.

Nixon DR, Yan DB, Chartrand JP, Piemontesi RL, Simonyi S, Hollander DA.

Curr Med Res Opin. 2009 Jul;25(7):1645-53. doi: 10.1185/03007990902994041.

PMID:
19476406
Items per page

Supplemental Content

Support Center